Healthcare Industry News: RRT
News Release - June 4, 2008
Draeger Announces FDA Clearance for New Ventilator - Carina(TM)
New Ventilator Added to Draeger's Family of Hospital, Sub-Acute, Home, Emergency and Transport Respiratory Care SolutionsTELFORD, Pa.--(HSMN NewsFeed)--Draeger Medical, Inc., the U.S. headquarters of Draeger Medical AG & Co. KG, an international leader in the field of medical technology and a worldwide leader in mechanical ventilation, announced today that it has received 510(k) clearance from the FDA to market the Carina, Draeger’s latest product in its ventilator product line to the U.S. market.
The Carina ventilator offers both invasive and non-invasive capabilities in one device. Its latest technology, known as “Synch Plus,” will compensate for leakage and provide effective breath delivery. The Carina is well-suited for the emergency room, general ward, ICU, or sub-acute facilities as it features an internal battery and can operate independent of a high-pressure gas system.
“This will allow clinicians a wide array of ventilation therapies in a single device characterized by ease of use and patient comfort,” said Ed Coombs, MA RRT, Director, Critical Care and Ventilation for Draeger Medical, Inc. “The transportability of the Carina makes patient transfer seamless and expedient, especially when a patient requires non-invasive support.”
For patients who are mechanically ventilated long-term, the Carina-home facilitates similar-style ventilation technology for chronic patients outside of the hospital. The Carina-home has been in the U.S. marketplace for over a year.
The Carina is expected to be commercially available by July 2008 in the United States. For more information, please visit Draeger Medical’s website at www.draeger.com or contact your local Draeger sales representative at 1-800-4DRAGER.
About Draeger
Draegerwerk AG & Co. KGaA is an international leader in the fields of medical and safety technology. Draeger products protect, support and save human life. Founded in 1889, in 2007 the Group achieved sales of 1,819.5 million Euro worldwide and an EBIT of 151.9 million Euro. Today, Draeger employs around 10,000 people in more than 70 subsidiaries worldwide and has representation in around 190 countries. The Draeger Medical subsidiary offers products, services and integrated system solutions which accompany the patient throughout the care process – Emergency Care, Perioperative Care, Critical Care or Perinatal Care and Home Mechanical Ventilation. For more information, visit www.draeger.com.
Source: Draeger Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
